ASR hip implants have been rejected in the U.S., but are still sold overseas

    ASR hip implants, rejected in U.S., still sold overseas  (MassDevice)
A new report reveals that Johnson & Johnson continued overseas sales of its metal-on-metal ASR hip implants after the FDA rejected them for the U.S. market.
Johnson & Johnson's metal-on-metal hip implants stayed on the market in Europe and other countries after they were rejected for the U.S. market, according to a report from the New York Times.
The implants were sold to patients overseas for a year after they were prohibited for U.S. patients, until they were recalled in August 2010 amid concerns about high fai...


Your friends are reading OrthoStreams daily - Are you ?

 

Unlock your access to full rich article, trends, hot startups, market reports and your daily newsletter.

Just $1/day.